Scott Jordan

Scott Jordan

Head Corporate Development

  • An accomplished senior-level executive with over 30 years of experience and successful track records in the life sciences industry.
  • Worked as Chief Business Officer for Inomagen Therapeutics and Salarius Pharmaceuticals.
  • Secured $2.6M in capital from an Equity Line sponsored by Aspire Capital for Salarius Pharmaceuticals and closed a $48M Reverse Merger with Flex Pharma listing the company on NASDAQ in 2019.
  • BA in Marketing from Michigan State University and an MBA from the Kellstadt Graduate School of Business at DePaul University.